QardioArm(R) Blood pressure monitoring in a population with Type 2 diabetes: Validation Study.
Loading...
Official URL
Full text at PDC
Publication date
2020
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
JMIR Publications
Citations
Exportar
Citation
Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, Martínez-Jiménez EM, Calvo-Lobo C, Romero-Morales C, López-López D, Palomo-López P QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study J Med Internet Res 2020;22(7):e19781 doi: 10.2196/19781 PMID: 32706672 PMCID: 7414407
Abstract
Background:
Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes.
Objective:
The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension.
Methods:
The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices.
Results:
The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes.
Conclusions:
This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.